Armstrong Advisory Group, Inc

SEC CIK: 0001932952
Latest filing: Jul 13, 2026

SEC filings (opens in a new tab)

ORTX holding history

Orchard Therapeutics plc in every 13F filed by Armstrong Advisory Group, Inc, including the quarters it was sold out or no filing was made. Changes compare share counts with the previous calendar quarter.

ORTX overview All 13F holders of ORTX Full Q2 2026 holdings

Shares (Q2 2023): 0; Sold out in Q2 2023
Value: $0
% of portfolio: 0.0%
Quarters held: 2; Since Q4 2022

Holdings of ORTX by Armstrong Advisory Group, Inc, by quarter
Quarter	Shares	Value	% of portfolio	Share change	Action	All holders
Q2 2023	0	$0	0.0%	−5−100.0%	Sold out	Holders
Q1 2023	5	$27	<0.1%	00.0%	UnchangedConverted for a 1-for-10 split	Holders
Q4 2022	50	$19	<0.1%	–	No prior filing	Holders